Board of Scientific Counselors, National Center for Injury Prevention and Control Meeting, 32759 [2016-12223]
Download as PDF
<![CDATA[
32759
Federal Register / Vol. 81, No. 100 / Tuesday, May 24, 2016 / Notices
Estimated Annualized Burden Hours
Number of
respondents
Type of respondents
Form name
Office-based physicians ..................................
Office-based physicians (non-respondents) ...
NAMCS CLAS questionnaire .........................
NAMCS CLAS Phone Script ..........................
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2016–12147 Filed 5–23–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
sradovich on DSK3TPTVN1PROD with NOTICES
Board of Scientific Counselors,
National Center for Injury Prevention
and Control Meeting
In accordance with Section 10(a) (2)
of the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces, the following meeting of the
aforementioned committee:
Time and Date: 1:00 p.m.–4:00 p.m.,
June 14, 2016 (CLOSED).
Place: Teleconference.
Status: The meeting as designated
above will be closed to the public in
accordance with provisions set forth in
Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the
Director, Management Analysis and
Services Office, CDC pursuant to Public
Law 92–463.
Purpose: The Board of Scientific
Counselors makes recommendations
regarding policies, strategies, objectives,
and priorities; and reviews progress
toward injury prevention goals and
provides evidence in injury preventionrelated research and programs. The
Board also provides advice on the
appropriate balance of intramural and
extramural research, the structure,
progress, and performance of intramural
programs. The Board is designed to
provide guidance on extramural
scientific program matters, including
the: (1) Review of extramural research
concepts for funding opportunity
announcements; (2) conduct of
Secondary Peer Review of extramural
research grants, cooperative agreements,
and contracts applications received in
response to the funding opportunity
announcements as it relates to the
Center’s programmatic balance and
VerDate Sep<11>2014
17:24 May 23, 2016
Jkt 238001
mission; (3) submission of secondary
review recommendations to the Center
Director of applications to be considered
for funding support; (4) review of
research portfolios, and (5) review of
program proposals. The board shall
provide guidance on the National Center
of Injury Prevention and Control’s
programs and research activities by
conducting scientific peer review of
intramural research and programs
within the National Center for Injury
Prevention and Control; by ensuring
adherence to Office of Management and
Budget requirements for intramural peer
review; and by monitoring the overall
direction, focus, and success of the
National Center for Injury Prevention
and Control.
Matters to Be Discussed: The BSC,
NCIPC will meet to conduct a
Secondary Peer Review of extramural
research grant applications received in
response to four (4) Funding
Opportunity Announcements (FOAs):
Research Grants for Preventing Violence
and Violence Related Injury (R01), FOA
RFA CE–16–001; Research to Advance
Primary Care-Pharmacy Linkage for
Medication Review to Reduce Older
Adult Falls, FOA RFA CE–16–002; The
CDC National Centers of Excellence in
Youth Violence Prevention: Building
the Evidence for Community- and
Policy-Level Prevention, FOA RFA CE–
15–002; and Research on Prescription
Opioid Use, Opioid Prescribing, and
Associated Heroin Risk, FOA RFA CE–
16–003. Applications will be assessed
for applicability to the Center’s mission
and programmatic balance.
Recommendations from the secondary
review will be voted upon and the
applications will be forwarded to the
Center Director for consideration for
funding support.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Gwendolyn H. Cattledge, Ph.D.,
M.S.E.H., Deputy Associate Director for
Science, NCIPC, CDC, 4770 Buford
Highway NE., Mailstop F–63, Atlanta,
GA 30341, Telephone (770) 488–1430.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
2,400
912
Average
burden per
response
(in hours)
1
1
15/60
5/60
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2016–12223 Filed 5–23–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Request for Nominations of
Candidates to Serve on the Advisory
Committee on Immunization Practices
(ACIP)
The Centers for Disease Control and
Prevention CDC is soliciting
nominations for membership on the
ACIP. The ACIP consists of 15 experts
in fields associated with immunization,
who are selected by the Secretary of the
U. S. Department of Health and Human
Services to provide advice and guidance
to the Secretary, the Assistant Secretary
for Health, and the CDC on the control
of vaccine-preventable diseases. The
role of the ACIP is to provide advice
that will lead to a reduction in the
incidence of vaccine preventable
diseases in the United States, and an
increase in the safe use of vaccines and
related biological products. The
committee also establishes, reviews, and
as appropriate, revises the list of
vaccines for administration to children
eligible to receive vaccines through the
Vaccines for Children (VFC) Program.
Nominations are being sought for
individuals who have expertise and
qualifications necessary to contribute to
the accomplishments of the committee’s
objectives. Nominees will be selected
based on expertise in the field of
immunization practices; multidisciplinary expertise in public health;
expertise in the use of vaccines and
immunologic agents in both clinical and
preventive medicine; knowledge of
vaccine development, evaluation, and
vaccine delivery; or knowledge about
E:\FR\FM\24MYN1.SGM
24MYN1
]]>Agencies
[Federal Register Volume 81, Number 100 (Tuesday, May 24, 2016)]
[Notices]
[Page 32759]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-12223]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Board of Scientific Counselors, National Center for Injury
Prevention and Control Meeting
In accordance with Section 10(a) (2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces, the following meeting of the aforementioned
committee:
Time and Date: 1:00 p.m.-4:00 p.m., June 14, 2016 (CLOSED).
Place: Teleconference.
Status: The meeting as designated above will be closed to the
public in accordance with provisions set forth in Section 552b(c)(4)
and (6), Title 5 U.S.C., and the Determination of the Director,
Management Analysis and Services Office, CDC pursuant to Public Law 92-
463.
Purpose: The Board of Scientific Counselors makes recommendations
regarding policies, strategies, objectives, and priorities; and reviews
progress toward injury prevention goals and provides evidence in injury
prevention-related research and programs. The Board also provides
advice on the appropriate balance of intramural and extramural
research, the structure, progress, and performance of intramural
programs. The Board is designed to provide guidance on extramural
scientific program matters, including the: (1) Review of extramural
research concepts for funding opportunity announcements; (2) conduct of
Secondary Peer Review of extramural research grants, cooperative
agreements, and contracts applications received in response to the
funding opportunity announcements as it relates to the Center's
programmatic balance and mission; (3) submission of secondary review
recommendations to the Center Director of applications to be considered
for funding support; (4) review of research portfolios, and (5) review
of program proposals. The board shall provide guidance on the National
Center of Injury Prevention and Control's programs and research
activities by conducting scientific peer review of intramural research
and programs within the National Center for Injury Prevention and
Control; by ensuring adherence to Office of Management and Budget
requirements for intramural peer review; and by monitoring the overall
direction, focus, and success of the National Center for Injury
Prevention and Control.
Matters to Be Discussed: The BSC, NCIPC will meet to conduct a
Secondary Peer Review of extramural research grant applications
received in response to four (4) Funding Opportunity Announcements
(FOAs): Research Grants for Preventing Violence and Violence Related
Injury (R01), FOA RFA CE-16-001; Research to Advance Primary Care-
Pharmacy Linkage for Medication Review to Reduce Older Adult Falls, FOA
RFA CE-16-002; The CDC National Centers of Excellence in Youth Violence
Prevention: Building the Evidence for Community- and Policy-Level
Prevention, FOA RFA CE-15-002; and Research on Prescription Opioid Use,
Opioid Prescribing, and Associated Heroin Risk, FOA RFA CE-16-003.
Applications will be assessed for applicability to the Center's mission
and programmatic balance. Recommendations from the secondary review
will be voted upon and the applications will be forwarded to the Center
Director for consideration for funding support.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Gwendolyn H. Cattledge, Ph.D.,
M.S.E.H., Deputy Associate Director for Science, NCIPC, CDC, 4770
Buford Highway NE., Mailstop F-63, Atlanta, GA 30341, Telephone (770)
488-1430.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2016-12223 Filed 5-23-16; 8:45 am]
BILLING CODE 4163-18-P
